Understanding oxidative and reductive stress (redox stress) in male fertility
While a standard semen analysis looks at count, movement, and shape, it doesn't always explain why conception is not occurring. There can be many other factors at play that don’t show up in a standard semen analysis and one of the major causes of impaired sperm quality is oxidative stress.
The balance: Oxidative vs. reductive stress
In healthy semen, there is a natural balance between Reactive Oxygen Species (ROS) and the body’s antioxidant defences, this is critical for sperm health and function as well as for general health.
Oxidative stress (OS) occurs when ROS production outweighs the available antioxidants which can lead to sperm DNA fragmentation and reduced fertilising potential. Possible causes of oxidative stress can include the overproduction of ROS due to infections, inflammation, or unhealthy lifestyle habits such as smoking, being overweight, or an insufficient intake of antioxidants like vitamins.
Reductive stress refers to an imbalance in the opposite direction to oxidative stress where there is an excess of antioxidants in the semen - often due to excess or over-supplementation of antioxidants. This "reductive stress" can be just as detrimental to fertility or general health as oxidative stress.
Recent data indicates that up to 15% of men with "normal" semen parameters experience reductive stress, whereas reports indicate that 30% to 80% of infertile men suffer from oxidative stress. Both conditions cannot be detected in a standard semen analysis.
Hence, for normal reproductive functions, a healthy balance between ROS and antioxidants, the so-called "redox balance" must be maintained.
The impact on fertility outcomes
Research consistently shows that an imbalance in seminal redox balance is associated with:
• Decreased rates of fertilisation and embryo development.
• Lower clinical pregnancy and live birth rates.
• In some cases, an increased risk of miscarriage.
Common triggers of oxidative stress
Physical/Medical: Varicocele, infections, high fever, diabetes, obesity, and advanced age.
Environmental: Heat exposure (tight clothing, sedentary desk work, hot baths), pollutants, and smoking.
Lifestyle: Poor diet, certain prescribed medicines and drug use and extended periods of sexual abstinence.
Common triggers of reductive stress
Triggers for reductive stress can be driven by over-supplementation of antioxidants, such as high-dose vitamin supplements, over-the-counter multivitamins, consumption of large quantities of antioxidant-rich smoothies but can also be influenced by chronic endurance exercise or certain medical conditions.
How the MiOXSYS system works
As compared with the common measurement of ROS or the total antioxidant capacity, testing for Oxidation-Reduction Potential (ORP) provides a more comprehensive picture of a man’s seminal redox balance and fertility potential if used in conjunction with a standard semen analysis and other diagnostic tests. The standard tests for ROS and total antioxidant capacity require specialised laboratory equipment, are rather large-scaled and therefore take long to obtain a result. In contrast, the MiOXSYS system is a point-of-care measurement of the redox balance, and the result is available within approximately 4 minutes.
At testhim we use the MiOXSYS system, a validated electrochemical tool that measures the static Oxidation-Reduction Potential (sORP). By placing a small amount of semen on a sensor, the device measures the transfer of electrons from antioxidants to oxidants. This provides a snapshot of the current oxidative state in your semen. Recent developments of the test may also allow us to measure the levels of the remaining antioxidants (capacity Oxidation-Reduction Potential; cORP) within the seminal fluid.
Interpreting the report
The test provides specific thresholds to guide your clinical management.
≤1.34 mV/106 sperm/mL - Normal value indicating good sperm fertilising potential, fertilisation and blastocyst formation rates, and pregnancy
>1.34 mV/106 sperm/mL - High oxidative stress that may warrant further investigation and treatment. A high ORP value is also indicative of a possible varicocele (a varicose vein at the scrotum).
For oxidative stress the statistically significant ORP threshold for subfertility has been established at >1.34 mV/106 sperm/ml.
Recent studies indicate that ORP values less than 0.00mV/106 sperm/ml are indicative of reductive stress.
Clinical management and treatment
The advantage of identifying oxidative stress levels is that they are often reversible. Based on your results, a specialist may recommend:
Lifestyle modifications: Weight loss, smoking cessation, dietary advice and temperature management (avoiding heated seats/hot baths).
Ejaculatory frequency: Reduce time of abstinence and increasing the frequency of ejaculation can reduce the time sperm are exposed to ROS, often improving pregnancy outcomes.
Medical intervention: Treatment of underlying infections with antibiotics or surgical repair of a varicocele.
Targeted nutrition: Using the test results to "right-size" antioxidant intake, ensuring you are treating a deficiency without causing reductive stress.
For reductive stress, a withdrawal of all exogenous antioxidant supplements, a reduction of the intake of antioxidant-dense foods (e.g. large quantities of antioxidant-rich smoothies and juices), or a graduated aerobic exercise programme to activate endogenous antioxidant regulation may improve the redox balance.
Summary
Redox stress testing in conjunction with other investigations offers a more comprehensive look at your fertility potential. By identifying these invisible barriers, we can create a more targeted treatment plan to improve your chances of a healthy, ongoing pregnancy.
References
Agarwal A, Arafa M, Chandrakumar R, Majzoub A, AlSaid S, Elbardisi H (2017); A multicenter study to evaluate oxidative stress by oxidation-reduction potential, a reliable and reproducible method. Andrology 5: 939-945
Agarwal A, Bui AD (2017); Oxidation-reduction potential as a new marker for oxidative stress: Correlation to male infertility. Investig Clin Urol 58: 385-399
Agarwal A, Henkel R, Sharma R, Tadros NN, Sabanegh E (2018); Determination of seminal oxidation-reduction potential (ORP) as an easy and cost-effective clinical marker of male infertility. Andrologia 50(3). doi: 10.1111/and.12914. Epub 2017 Oct 23.
Agarwal A, Parekh N, Panner Selvam MK, Henkel R, Shah R, Homa ST, Ramasamy R, Ko E, Tremellen K, Esteves S, Majzoub A, Alvarez JG, Gardner DK, Jayasena CN, Ramsay JW, Cho CL, Saleh R, Sakkas D, Hotaling JM, Lundy SD, Vij S, Marmar J, Gosalvez J, Sabanegh E, Park HJ, Zini A, Kavoussi P, Micic S, Smith R, Busetto GM, Bakircioglu ME, Haidl G, Balercia G, Puchalt NG, Ben-Khalifa M, Tadros N, Kirkman-Browne J, Moskovtsev S, Huang X, Borges E, Franken D, Bar-Chama N, Morimoto Y, Tomita K, Srini VS, Ombelet W, Baldi E, Muratori M, Yumura Y, La Vignera S, Kosgi R, Martinez MP, Evenson DP, Zylbersztejn DS, Roque M, Cocuzza M, Vieira M, Ben-Meir A, Orvieto R, Levitas E, Wiser A, Arafa M, Malhotra V, Parekattil SJ, Elbardisi H, Carvalho L, Dada R, Sifer C, Talwar P, Gudeloglu A, Mahmoud AMA, Terras K, Yazbeck C, Nebojsa B, Durairajanayagam D, Mounir A, Kahn LG, Baskaran S, Pai RD, Paoli D, Leisegang K, Moein MR, Malik S, Yaman O, Samanta L, Bayane F, Jindal SK, Kendirci M, Altay B, Perovic D, Harlev A (2019); Male Oxidative Stress Infertility (MOSI): Proposed terminology and clinical practice guidelines for management of idiopathic male infertility. World J Mens Health 37: 296-312
Agarwal A, Roychoudhury S, Bjugstad KB, Cho CL (2016); Oxidation-reduction potential of semen: what is its role in the treatment of male infertility? Ther Adv Urol 8: 302-318
Agarwal A, Roychoudhury S, Sharma R, Gupta S, Majzoub A, Sabanegh E (2017); Diagnostic application of oxidation-reduction potential assay for measurement of oxidative stress: clinical utility in male factor infertility. Reprod Biomed Online 34: 48-57
Agarwal A, Sharma R, Roychoudhury S, Du Plessis S, Sabanegh E (2016); MiOXSYS: a novel method of measuring oxidation reduction potential in semen and seminal plasma. Fertil Steril 106: 566-573
Arafa M, Henkel R, Agarwal A, Majzoub A, Elbardisi H (2019); Correlation of oxidation-reduction potential with hormones, semen parameters and testicular volume. Andrologia 51: e13258
Bhengu SI, Henkel R, Huyser C (2025); Delayed embryonic development: The predictive potential of seminal oxidative stress in human embryo development. Hum Reprod 40(Suppl 1): i230
Cannarella R, Crafa A, Barbagallo F, Mongioì LM, Condorelli RA, Aversa A, Calogero AE, La Vignera S (2020); Seminal plasma proteomic biomarkers of oxidative stress. Int J Mol Sci 21(23): 9113
Castagné V, Lefèvre K, Natero R, Clarke PG, Bedker DA (1999); An optimal redox status for the survival of axotomized ganglion cells in the developing retina. Neuroscience 93: 313-320
Christoforaki V, Venetis C, Goulis DG, Zepiridis L, Chatzimeletiou K, Mitsoli A, Savvaidou D, Grimbizis G, Kolibianakis EM (2025); The role of seminal oxidation-reduction potential in male infertility: systematic review and meta-analysis. Reprod Biomed Online. 2025 Feb 4:104858. doi: 10.1016/j.rbmo.2025.104858. Online ahead of print.
Dimitriadis F, Tsounapi P, Zachariou A, Kaltsas A, Sokolakis I, Hatzichristodoulou G, Symeonidis EN, Kotsiris D, Gabales MR, Vlachopoulou E, Takenaka A, Sofikitis N (2021); Therapeutic effects of micronutrient supplements on sperm parameters: Fact or fiction? Curr Pharm Des 27: 2757-2769
Dutta S, Sengupta P, Alahmar AT, Dasgupta S, Bahadur G, Henkel R, ur Rehman K, Bhalerao A (2026); Antioxidants in male infertility: Towards precision therapy - What to use, When, and at What dose? Chem Biol Lett 13(3): 1774
Henkel R (2024); Antioxidant paradox. In: Andreescu S, Henkel R, Khelfi A (eds.); Biomarkers of Oxidative Stress – Clinical Aspects of Oxidative Stress. Springer Nature Switzerland, Cham, Switzerland, pp. 349-360
Henkel R (2024); MiOXSYS. In: Andreescu S, Henkel R, Khelfi A (eds.); Biomarkers of Oxidative Stress – Basics and Measurement of Oxidative Stress. Springer International Publishing, pp. 489-496
Henkel R, Morris A, Vogiatzi P, Saleh R, Sallam H, Boitrelle F, Garrido N, Arafa M, Gül M, Rambhatla A, Maldonado Rosas I, Agarwal A, Leisegang K, Siebert TI (2022); Predictive value of seminal oxidation-reduction potential (ORP) analysis for reproductive outcomes of intracytoplasmic sperm injection (ICSI) cycles. Reprod Biomed Online 45(5): 1007-1020
Henkel R, Sandhu IS, Agarwal A (2019); The excessive use of antioxidant therapy: A possible cause of male infertility? Andrologia 51: e13162
Moustakli E, Zikopoulos A, Skentou C, Katopodis P, Domali E, Potiris A, Stavros S, Zachariou A (2024); Impact of reductive stress on human infertility: Underlying mechanisms and perspectives. Int J Mol Sci 25(21): 11802
Peramo B, Upadhyay D, Bouhafs L, Alsafar H (2026); Redox imbalance in infertility and assisted reproduction: biomarkers, mechanisms, multi-omics integration, and personalised therapeutic strategies. Front Med (Lausanne) 13: 1870154
Prepared by: Prof R Henkel
Reviewed by: Prof R Henkel - 05/10/26
